🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to see what dose of 225Ac-lintuzumab is safest...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02-28
Trial ID
NCT03705858
Treatments Being Tested
The study is a multicenter, open label Phase I/II trial. 1. Establish the ...
Status
Completed
Location
UCLA Medical Center, Division of Hematology/Oncology
Start Date
2012-10
Trial ID
NCT02575963
Treatments Being Tested
The purpose of this study is to assess whether there is a survival benefit ...
Status
Completed
Location
Southern Cancer Center
Start Date
2007-09
Trial ID
NCT00528333
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1996-07
Trial ID
NCT00002800
Treatments Being Tested
The study is a multicenter, open label Phase I/II trial. 1. To determine t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT03932318
Treatments Being Tested
This phase I trial studies the side effects and best dose of Actimab-A when...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07422363
1. Establish the MTD of Lintuzumab-Ac225 as monotherapy 2. Establish overal...
Status
Terminated
Location
UCLA
Start Date
2016-12
Trial ID
NCT02998047
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as azacitidine, work in differe...
Status
Terminated
Location
Ohio State University Medical Center
Start Date
2009-11
Trial ID
NCT00997243
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of lintuzum...
Status
Suspended
Location
Dana-Farber - Harvard Cancer Center LAO
Start Date
2026-09-03
Trial ID
NCT06888323
The study is a multicenter, open label Phase I/II trial. 1. To determine t...
Status
Unknown
Location
University of California
Start Date
2020-01-15
Trial ID
NCT03867682
Treatments Being Tested